Good to see this finally happening even though this is all expected.
Frank did alright with Juniper Pharmaceuticals as CEO 2009-2016
https://www.reuters.com/article/us-juniper-pharms-m-a-catalent-idUSKBN1JT0WL
Start date: 08/26/2011 1 End date: 08/14/2018 2 Start price/share: $2.07 3 End price/share: $11.50 4 Dividends collected/share: $0.00 5 Total return: 455.56% 6 Average Annual Total Return: 27.88%
Before that Skyepharma from 2006-2016 ( CEO/Board/Chairman )
https://www.biospace.com/article/releases/skyepharma-plc-makes-senior-appointments-new-ceo-coo-/
Eventually was acquired
https://www.reuters.com/article/us-skyepharma-m-a-vectura-grp-idUSKCN0WI1A9
And Ivax was sold to TEVA before that.
Ann: Mayne Pharma board renewal and new Chairman, page-8
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.71 |
Change
0.070(1.51%) |
Mkt cap ! $400.7M | |||
| Open | High | Low | Value | Volume |
| $4.67 | $4.75 | $4.62 | $953.1K | 203.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1236 | $4.71 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.72 | 620 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MYX (ASX) Chart |